VacV Biotech

About:

VacV Biotech develops an oncolytic virus platform based on the vaccinia virus.

Website: https://vacvbtx.com/

Twitter/X: VacVBtx

Top Investors: Prox Ventures

Description:

VacV Biotherapeutics develops an oncolytic virus platform based on the vaccinia virus. The platform genetically modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular enveloped virus (EEV). It has higher safety and efficiency and can be administered by intravenous injection.